CWM
RVMD icon

Congress Wealth Management’s Revolution Medicines RVMD Stock Holding History

Congress Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$681K Buy
18,520
+15
+0.1% +$576 0.01% 821
2025
Q1 		$654K Buy
+18,505
New +$751K 0.01% 739

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Congress Wealth Management's RVMD Position: Q2 2025 in Review

Congress Wealth Management increased its Revolution Medicines (RVMD) stake by 0.08% in Q2 2025, buying an estimated $576 and bringing the position to 18,520 shares worth $681K. The position accounts for 0.01% of the portfolio, ranked #821.

Congress Wealth Management first reported a position in RVMD in Q1 2025 and has held it in 2 quarters since. 308 funds tracked by Wall St. Rank hold RVMD as of Q2 2025.

  • Congress Wealth Management held 18,520 shares of Revolution Medicines worth $681K as of Q2 2025.
  • Congress Wealth Management bought 15 Revolution Medicines shares in Q2 2025, an estimated $576.
  • Revolution Medicines made up 0.01% of Congress Wealth Management's portfolio in Q2 2025, its #821 holding.
  • Congress Wealth Management first reported a position in Revolution Medicines in Q1 2025 and has held it in 2 quarters since.
  • 308 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.